MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPa (C/EBPa-Cm)-induced myeloid leukemia

International Journal of Hematology

Volumn 96, Issue 3, 2012, Pages 334-341

  Enomoto, Yutaka ^a   Kitaura, Jiro ^a   Shimanuki, Masaya ^b   Kato, Naoko ^a   Nishimura, Koutarou ^a   Takahashi, Mariko ^a   Nakakuma, Hideki ^b   Kitamura, Toshio ^a   Sonoki, Takashi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

AML; microRNA 125b 1; Oncogene

Indexed keywords

BCR ABL PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD11B ANTIGEN; GREEN FLUORESCENT PROTEIN; MICRORNA 125B; MICRORNA 125B 1; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL EXPANSION; CONTROLLED STUDY; GENETIC TRANSFECTION; LEUKEMOGENESIS; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PROTEIN EXPRESSION; SPLEEN; THYMUS;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; DISEASE PROGRESSION; GENE EXPRESSION; LEUKEMIA, MYELOID; MICE; MICRORNAS; MUTATION; MYELOID CELLS; TRANSDUCTION, GENETIC;

EID: 84866992579     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1143-5     Document Type: Article

References (24)

1. Sonoki T, Iwanaga E, Mitsuya H, Asou N. Insertion of microRNA- 125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia. 2005;19:2009-10.
2. Chapiro E, Russell LJ, Struski S, Cavé H, Radford-Weiss I, Valle VD, et al. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia. 2010;24(7):1362-4.
3. Tassano E, Acquila M, Tavella E, Micalizzi C, Panarello C, Morerio C. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia. Genes Chromosom Cancer. 2010;49:682-7.
4. Enomoto Y, Kitaura J, Hatakeyama K, Watanuki J, Akasaka T, Kato N, et al. El/miR-125b transgenic mice develop lethal B-cell malignancies. Leukemia. 2011;25:1849-56.
5. Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, et al. Myeloid cell differentiation arrest by miR- 125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med. 2008;205:2499-506.
6. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci USA. 2010;107:14235-40.
7. Ooi AG, Sahoo D, Adorno M, Wang Y, Weissman IL, Park CY. MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc Natl Acad Sci USA. 2010;107:21505-10.
8. Bousquet M, HarrisMH, ZhouB, LodishHF. MicroRNAmiR-125b causes leukemia. Proc Natl Acad Sci USA. 2010;107:21558-63.
9. Somervaille TC, Cleary ML. Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells? Int J Hematol. 2010;91:735-41.
10. Goyama S, Mulloy JC. Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects. Int J Hematol. 2011;94:126-33.
11. Renneville A, Roumier C, Biggio V, Nibourel O, Boissel N, Fenaux P, et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia. 2008;22:915-31.
12. Kato N, Kitaura J, Doki N, Komeno Y, Watanabe-Okochi N, Togami K, et al. Two types of C/EBPa mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models. Blood. 2011;117:221-33.
13. Ono R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki T, et al. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. J Clin Invest. 2005;115:919-29.
14. Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, et al. PML/RARalpha and FLT3-ITD induce an APLlike disease in a mouse model. Proc Natl Acad Sci USA. 2002;99:8283-8.
15. Iwasaki M, Kuwata T, Yamazaki Y, Jenkins NA, Copeland NG, Osato M, et al. Identification of cooperative genes for NUP98- HOXA9 in myeloid leukemogenesis using a mouse model. Blood. 2005;105:784-93.
16. Ding Y, Harada Y, Imagawa J, Kimura A, Harada H. AML1/ RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms. Blood. 2009;114:5201-5.
17. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci US A. 2007;104:19983-8.
18. Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V, et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 2009;23:862-76.
19. Xia H, He T, Liu C, Cui Y, Song P, Jin X, et al. MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem. 2009;23:347-58.
20. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7:1063-6.
21. Watanabe-Okochi N, Oki T, Komeno Y, Kato N, Yuji K, Ono R, et al. Possible involvement of RasGRP4 in leukemogenesis. Int J Hematol. 2009;89:470-81.
22. Kitamura T, KoshinoY, Shibata F,OkiT,NakajimaH,NosakaT, et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol. 2003;31:1007-14.
23. Enomoto Y, Yamanishi Y, Izawa K, Kaitani A, Takahashi M, Maehara A, et al. Characterization of leukocyte mono-immunoglobulin- like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5. J Biol Chem. 2010;285:35274-83.
24. O'Connell RM, Zhao JL, Rao DS. MicroRNA function in myeloid biology. Blood. 2011;118:2960-9.